Geode Capital Management
PAVM icon

Geode Capital Management’s PAVmed PAVM Stock Holding History

Geode Capital Management’s Portfolio PAVM Stock Details PAVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$120K Buy
11,777
+6,149
+109% +$58.2K ﹤0.01% 4088
2025
Q4 		$39.8K Buy
5,628
+2,409
+75% +$27.5K ﹤0.01% 4273
2025
Q3 		$41.8K Buy
3,219
+263
+9% +$3.91K ﹤0.01% 4329
2025
Q2 		$53.2K Sell
2,956
-133
-4% -$2.66K ﹤0.01% 4203
2025
Q1 		$66.9K Buy
3,089
+440
+17% +$9.12K ﹤0.01% 4136
2024
Q4 		$49.9K Sell
2,649
-101
-4% -$2.98K ﹤0.01% 4244
2024
Q3 		$101K Buy
2,750
+296
+12% +$9.08K ﹤0.01% 4100
2024
Q2 		$60K Buy
2,454
+342
+16% +$17.1K ﹤0.01% 4243
2024
Q1 		$136K Buy
2,112
+276
+15% +$20.9K ﹤0.01% 4058
2023
Q4 		$227K Hold
1,836
– – ﹤0.01% 3894
2023
Q3 		$243K Buy
1,836
+204
+13% +$31.6K ﹤0.01% 3906
2023
Q2 		$300K Hold
1,632
– – ﹤0.01% 3858
2023
Q1 		$274K Hold
1,632
– – ﹤0.01% 3902
2022
Q4 		$352K Buy
1,632
+13
+0.8% +$4.91K ﹤0.01% 3831
2022
Q3 		$626K Sell
1,619
-79
-5% -$44.8K ﹤0.01% 3610
2022
Q2 		$714K Sell
1,698
-1,089
-39% -$526K ﹤0.01% 3570
2022
Q1 		$1.66M Buy
2,787
+42
+2% +$31.2K ﹤0.01% 3356
2021
Q4 		$3.04M Buy
2,745
+39
+1% +$84.8K ﹤0.01% 3163
2021
Q3 		$10.4M Sell
2,706
-10
-0.4% -$31.5K ﹤0.01% 2435
2021
Q2 		$7.82M Buy
2,716
+404
+17% +$954K ﹤0.01% 2632
2021
Q1 		$4.62M Buy
2,312
+1,105
+92% +$1.66M ﹤0.01% 2827
2020
Q4 		$1.15M Buy
1,207
+336
+39% +$287K ﹤0.01% 3326
2020
Q3 		$697K Buy
871
+48
+6% +$42.7K ﹤0.01% 3325
2020
Q2 		$781K Buy
823
+612
+290% +$612K ﹤0.01% 3225
2020
Q1 		$188K Buy
211
+54
+34% +$44.2K ﹤0.01% 3571
2019
Q4 		$84K Hold
157
– – ﹤0.01% 4006
2019
Q3 		$67K Hold
157
– – ﹤0.01% 4024
2019
Q2 		$80K Hold
157
– – ﹤0.01% 4002
2019
Q1 		$77K Hold
157
– – ﹤0.01% 3945
2018
Q4 		$67K Hold
157
– – ﹤0.01% 3939
2018
Q3 		$91K Buy
+157
New +$95.8K ﹤0.01% 3952

Other funds holding PAVM

TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $3.65B AUM 41.88% 1-Year Est. Return

Geode Capital Management's PAVM Position: Q1 2026 in Review

Geode Capital Management increased its PAVmed (PAVM) stake by 109% in Q1 2026, buying an estimated $58.2K and bringing the position to 11,777 shares worth $120K. The position accounts for ﹤0.01% of the portfolio, ranked #4088.

Geode Capital Management first reported a position in PAVM in Q3 2018 and has held it in 31 quarters since. The position peaked at $10.4M in Q3 2021. 20 funds tracked by Wall St. Rank hold PAVM as of Q1 2026.

  • Geode Capital Management held 11,777 shares of PAVmed worth $120K as of Q1 2026.
  • Geode Capital Management bought 6,149 PAVmed shares in Q1 2026, an estimated $58.2K.
  • PAVmed made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #4088 holding.
  • Geode Capital Management first reported a position in PAVmed in Q3 2018 and has held it in 31 quarters since.
  • Geode Capital Management's PAVmed position peaked at $10.4M in Q3 2021.
  • 20 funds tracked by Wall St. Rank held PAVmed as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.